The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
the other thing about berberine and this is that this is when I still do use it in clinical practice is it is also a weak inhibitor of the enzyme pcsk9 which any listener this podcast is going to be very well up to speed on what pcsk9 is the word on the street is it probably only works in a subset of people who over express pcsk9
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
so berberine is a plant derived extract that has two properties one of which it gets a lot of attention for one of which it might not be as well known